DENND1C
gene geneOn this page
Also known as FLJ22757
Summary
DENND1C (DENN domain containing 1C, HGNC:26225) is a protein-coding gene on chromosome 19p13.3, encoding DENN domain-containing protein 1C (Q8IV53). Guanine nucleotide exchange factor (GEF) which may activate RAB8A, RAB13 and RAB35.
The protein encoded by this gene functions as a guanine nucleotide exchange factor for the early endosomal small GTPase RAB35, which regulates endosomal membrane trafficking and is involved in actin polymerization. The encoded protein activates RAB35 by promoting the exchange of RAB35-bound GDP for GTP. This gene may play a role in linking RAB35 activation with the clathrin machinery.
Source: NCBI Gene 79958 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 142 total
- MANE Select transcript:
NM_024898
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26225 |
| Approved symbol | DENND1C |
| Name | DENN domain containing 1C |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ22757 |
| Ensembl gene | ENSG00000205744 |
| Ensembl biotype | protein_coding |
| OMIM | 613634 |
| Entrez | 79958 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 7 protein_coding, 6 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000381480, ENST00000543576, ENST00000586046, ENST00000588421, ENST00000588988, ENST00000589491, ENST00000590173, ENST00000590444, ENST00000590473, ENST00000590818, ENST00000590867, ENST00000591030, ENST00000591795, ENST00000592543, ENST00000871258, ENST00000871259
RefSeq mRNA: 2 — MANE Select: NM_024898
NM_001290331, NM_024898
CCDS: CCDS45938, CCDS77225
Canonical transcript exons
ENST00000381480 — 23 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001488740 | 6475484 | 6475585 |
| ENSE00001488742 | 6475706 | 6475751 |
| ENSE00001488743 | 6475837 | 6475937 |
| ENSE00001488745 | 6476857 | 6476967 |
| ENSE00002744131 | 6481679 | 6481787 |
| ENSE00003465647 | 6469596 | 6469640 |
| ENSE00003474056 | 6468846 | 6468953 |
| ENSE00003477721 | 6478783 | 6478852 |
| ENSE00003541469 | 6479859 | 6479902 |
| ENSE00003556519 | 6478937 | 6479056 |
| ENSE00003558130 | 6479669 | 6479718 |
| ENSE00003562700 | 6477074 | 6477127 |
| ENSE00003565388 | 6479987 | 6480051 |
| ENSE00003613593 | 6468578 | 6468645 |
| ENSE00003618151 | 6470295 | 6470366 |
| ENSE00003620433 | 6472889 | 6472993 |
| ENSE00003632228 | 6467207 | 6468118 |
| ENSE00003635806 | 6471265 | 6471305 |
| ENSE00003639100 | 6477378 | 6477458 |
| ENSE00003662374 | 6468234 | 6468441 |
| ENSE00003664331 | 6475274 | 6475399 |
| ENSE00003694631 | 6471406 | 6471496 |
| ENSE00003784953 | 6477218 | 6477283 |
Expression profiles
Bgee: expression breadth ubiquitous, 180 present calls, max score 97.83.
FANTOM5 (CAGE): breadth broad, TPM avg 8.2528 / max 177.5732, expressed in 633 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 178649 | 7.2644 | 501 |
| 178648 | 0.7519 | 219 |
| 178647 | 0.2365 | 147 |
Top tissues by expression
269 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 97.83 | gold quality |
| spleen | UBERON:0002106 | 93.48 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 92.80 | gold quality |
| lymph node | UBERON:0000029 | 92.74 | gold quality |
| rectum | UBERON:0001052 | 92.12 | gold quality |
| blood | UBERON:0000178 | 92.02 | gold quality |
| leukocyte | CL:0000738 | 90.24 | gold quality |
| monocyte | CL:0000576 | 89.85 | gold quality |
| mononuclear cell | CL:0000842 | 89.82 | gold quality |
| vermiform appendix | UBERON:0001154 | 89.75 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 88.87 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 88.72 | gold quality |
| islet of Langerhans | UBERON:0000006 | 87.76 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 87.31 | gold quality |
| small intestine | UBERON:0002108 | 86.75 | gold quality |
| body of pancreas | UBERON:0001150 | 86.56 | gold quality |
| skin of leg | UBERON:0001511 | 86.55 | gold quality |
| bone marrow cell | CL:0002092 | 86.09 | gold quality |
| pancreas | UBERON:0001264 | 85.68 | gold quality |
| transverse colon | UBERON:0001157 | 85.54 | gold quality |
| skin of abdomen | UBERON:0001416 | 85.53 | gold quality |
| upper lobe of lung | UBERON:0008948 | 85.48 | gold quality |
| caecum | UBERON:0001153 | 85.39 | gold quality |
| body of stomach | UBERON:0001161 | 85.36 | gold quality |
| esophagus mucosa | UBERON:0002469 | 85.36 | gold quality |
| right lobe of liver | UBERON:0001114 | 84.94 | gold quality |
| metanephros cortex | UBERON:0010533 | 84.94 | gold quality |
| gall bladder | UBERON:0002110 | 84.85 | gold quality |
| right lung | UBERON:0002167 | 84.21 | gold quality |
| minor salivary gland | UBERON:0001830 | 84.02 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.35 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
25 targeting DENND1C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-4320 | 99.75 | 65.80 | 793 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-3125 | 99.14 | 68.49 | 2269 |
| HSA-MIR-4504 | 99.10 | 69.14 | 1328 |
| HSA-MIR-3916 | 98.99 | 68.04 | 2155 |
| HSA-MIR-5006-5P | 98.79 | 66.92 | 1246 |
| HSA-MIR-6769B-5P | 98.73 | 64.91 | 1092 |
| HSA-MIR-4733-3P | 98.35 | 65.20 | 994 |
| HSA-MIR-876-5P | 97.99 | 68.49 | 1345 |
| HSA-MIR-3650 | 97.88 | 64.89 | 693 |
| HSA-MIR-4456 | 97.50 | 64.88 | 1678 |
| HSA-MIR-10400-3P | 97.29 | 64.66 | 597 |
| HSA-MIR-4674 | 97.29 | 64.62 | 597 |
| HSA-MIR-6515-5P | 97.08 | 65.48 | 1219 |
| HSA-MIR-4474-3P | 96.97 | 65.87 | 870 |
| HSA-MIR-3616-3P | 96.96 | 65.45 | 983 |
| HSA-MIR-3126-5P | 96.87 | 65.83 | 912 |
| HSA-MIR-6875-5P | 96.87 | 65.49 | 958 |
| HSA-MIR-3167 | 96.81 | 67.09 | 1236 |
| HSA-MIR-3139 | 96.68 | 66.77 | 652 |
| HSA-MIR-6834-5P | 96.25 | 64.88 | 823 |
Literature-anchored findings (GeneRIF, showing 1)
- whereas connecdenn 1 and 2 activate Rab35 for endosomal trafficking, connecdenn 3 uniquely activates Rab35 for its role in actin regulation (PMID:22072793)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dennd1c | ENSDARG00000078503 |
| mus_musculus | Dennd1c | ENSMUSG00000002668 |
| rattus_norvegicus | Dennd1c | ENSRNOG00000046050 |
| drosophila_melanogaster | CG18659 | FBGN0027561 |
| caenorhabditis_elegans | WBGENE00004375 |
Paralogs (2): DENND1A (ENSG00000119522), DENND1B (ENSG00000213047)
Protein
Protein identifiers
DENN domain-containing protein 1C — Q8IV53 (reviewed: Q8IV53)
Alternative names: Connecdenn 3, Protein FAM31C
All UniProt accessions (6): Q8IV53, K7EKL5, K7EM30, K7EM80, K7EMN9, K7ENM0
UniProt curated annotations — full annotation on UniProt →
Function. Guanine nucleotide exchange factor (GEF) which may activate RAB8A, RAB13 and RAB35. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form.
Subunit / interactions. Exhibits low nucleotide-independent RAB35-binding activity. Interacts with clathrin heavy chain/CLTC and with AP2A2, but not with AP2B1.
Subcellular location. Cytoplasm. Cytosol. Cytoplasmic vesicle. Clathrin-coated vesicle.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IV53-1 | 1 | yes |
| Q8IV53-2 | 2 |
RefSeq proteins (2): NP_001277260, NP_079174* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001194 | cDENN_dom | Domain |
| IPR005112 | dDENN_dom | Domain |
| IPR005113 | uDENN_dom | Domain |
| IPR037516 | Tripartite_DENN | Domain |
| IPR040032 | DENND1A/B/C | Family |
| IPR043153 | DENN_C | Homologous_superfamily |
Pfam: PF02141, PF03455, PF03456
UniProt features (24 total): compositionally biased region 8, domain 3, sequence variant 3, sequence conflict 3, region of interest 2, short sequence motif 2, chain 1, modified residue 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IV53-F1 | 63.79 | 0.41 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 553
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs |
MSigDB gene sets: 129 (showing top):
GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, BOYLAN_MULTIPLE_MYELOMA_D_DN, GOCC_COATED_VESICLE, GOBP_ENDOCYTIC_RECYCLING, GOBP_LOCALIZATION_WITHIN_MEMBRANE, GOBP_IMPORT_INTO_CELL, GOBP_ENDOCYTOSIS, GOCC_CLATHRIN_COATED_VESICLE, GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY, chr19p13, GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING, GOMF_PHOSPHATIDYLINOSITOL_BINDING, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY
GO Biological Process (2): endocytosis (GO:0006897), endocytic recycling (GO:0032456)
GO Molecular Function (3): guanyl-nucleotide exchange factor activity (GO:0005085), phosphatidylinositol phosphate binding (GO:1901981), protein binding (GO:0005515)
GO Cellular Component (6): nucleoplasm (GO:0005654), centrosome (GO:0005813), cytosol (GO:0005829), clathrin-coated vesicle (GO:0030136), cytoplasm (GO:0005737), cytoplasmic vesicle (GO:0031410)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Rab regulation of trafficking | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cytoplasm | 2 |
| vesicle budding from membrane | 1 |
| membrane invagination | 1 |
| vesicle-mediated transport | 1 |
| import into cell | 1 |
| endosomal transport | 1 |
| vesicle-mediated transport to the plasma membrane | 1 |
| GTP binding | 1 |
| GDP binding | 1 |
| GTPase regulator activity | 1 |
| phospholipid binding | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| coated vesicle | 1 |
| intracellular anatomical structure | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
698 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DENND1C | RAB35 | Q15286 | 930 |
| DENND1C | CLTC | Q00610 | 726 |
| DENND1C | RAB13 | P51153 | 589 |
| DENND1C | RAB28 | P51157 | 448 |
| DENND1C | MADD | Q8WXG6 | 438 |
| DENND1C | RAB21 | Q9UL25 | 432 |
| DENND1C | SYP | P08247 | 427 |
| DENND1C | DENND4B | O75064 | 420 |
| DENND1C | DENND5B | Q6ZUT9 | 412 |
| DENND1C | DENND3 | A2RUS2 | 401 |
| DENND1C | RAB22A | Q9UL26 | 398 |
| DENND1C | AVL9 | Q8NBF6 | 394 |
| DENND1C | RABIF | P47224 | 386 |
| DENND1C | WDR83OS | Q9Y284 | 375 |
| DENND1C | SLC37A3 | Q8NCC5 | 369 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DENND1C | SNAPIN | psi-mi:“MI:0915”(physical association) | 0.560 |
| SNAPIN | DENND1C | psi-mi:“MI:0915”(physical association) | 0.560 |
| DENND1C | DAPK1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| DENND1C | HSPA8 | psi-mi:“MI:0915”(physical association) | 0.400 |
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
| DENND1C | cysJ | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (8): DENND1C (Reconstituted Complex), DENND1C (Affinity Capture-MS), DENND1C (Two-hybrid), DENND1C (Proximity Label-MS), DENND1C (Affinity Capture-RNA), DENND1C (Affinity Capture-MS), DENND1C (Affinity Capture-RNA), APP (Reconstituted Complex)
ESM2 similar proteins: A1L3T7, A2CI98, A2CJ06, A2VCK2, D3ZQL6, E1BBG2, M3WHG5, O15037, O43918, O70303, O75333, P48778, P59729, Q32PJ7, Q3KP66, Q3T191, Q5JYT7, Q5T124, Q5U4F0, Q5XIS1, Q6AXX1, Q6VYH9, Q7TSI1, Q80U38, Q8BGT6, Q8BHW9, Q8BWG4, Q8BWQ5, Q8BZ33, Q8BZW2, Q8C0J6, Q8C2K5, Q8CFK6, Q8IV53, Q8IY33, Q8IZW8, Q8K1S6, Q8K330, Q8N3F8, Q8TB24
Diamond homologs: A2RSQ0, C8YR32, G3V7Q0, Q5FVJ0, Q6IQ26, Q6NXD8, Q6P3S1, Q6PAL8, Q6ZUT9, Q8BIJ7, Q8C4S8, Q8CFK6, Q8IV53, Q8IVV2, Q8RXA7, Q8WXG6, Q96T51, Q9TXP3, E9PXF8, G2WWH6, I1RQE2, O02626, O75064, O95248, P78524, Q3U1T9, Q3U1Y4, Q5VZ89, Q68D51, Q68F67, Q6NTN5, Q6ZPE2, Q7Z401, Q86WG5, Q8K382, Q8TEH3, Q91VV4, Q924W7, Q9H6A0, Q9ULE3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
142 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 111 |
| Likely benign | 13 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3428 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:6468119:C:CC | acceptor_gain | 1.0000 |
| 19:6468442:C:CC | acceptor_gain | 1.0000 |
| 19:6468949:CCATC:C | acceptor_gain | 1.0000 |
| 19:6468950:CATC:C | acceptor_gain | 1.0000 |
| 19:6468950:CATCC:C | acceptor_gain | 1.0000 |
| 19:6468952:TC:T | acceptor_gain | 1.0000 |
| 19:6468953:CC:C | acceptor_gain | 1.0000 |
| 19:6468953:CCTA:C | acceptor_loss | 1.0000 |
| 19:6468954:C:CA | acceptor_loss | 1.0000 |
| 19:6468954:C:CC | acceptor_gain | 1.0000 |
| 19:6468955:T:C | acceptor_loss | 1.0000 |
| 19:6470287:AG:A | donor_gain | 1.0000 |
| 19:6471400:GCTCA:G | donor_loss | 1.0000 |
| 19:6471401:CTCA:C | donor_loss | 1.0000 |
| 19:6471402:TCA:T | donor_loss | 1.0000 |
| 19:6471403:CA:C | donor_loss | 1.0000 |
| 19:6471405:C:CT | donor_loss | 1.0000 |
| 19:6471493:TGAA:T | acceptor_gain | 1.0000 |
| 19:6471497:C:CC | acceptor_gain | 1.0000 |
| 19:6471511:A:T | acceptor_gain | 1.0000 |
| 19:6471518:C:CT | acceptor_gain | 1.0000 |
| 19:6472993:CCTGG:C | acceptor_loss | 1.0000 |
| 19:6475273:CCGGG:C | donor_gain | 1.0000 |
| 19:6475480:TGACC:T | donor_loss | 1.0000 |
| 19:6475481:GAC:G | donor_loss | 1.0000 |
| 19:6475482:A:AC | donor_gain | 1.0000 |
| 19:6475482:A:C | donor_loss | 1.0000 |
| 19:6475483:C:CC | donor_gain | 1.0000 |
| 19:6475483:CCA:C | donor_gain | 1.0000 |
| 19:6475483:CCACG:C | donor_gain | 1.0000 |
AlphaMissense
5183 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:6475887:C:A | W243C | 0.999 |
| 19:6475887:C:G | W243C | 0.999 |
| 19:6475889:A:G | W243R | 0.999 |
| 19:6475889:A:T | W243R | 0.999 |
| 19:6475728:C:T | G268E | 0.998 |
| 19:6475734:A:G | L266P | 0.998 |
| 19:6475738:A:C | Y265D | 0.998 |
| 19:6476888:C:A | R216I | 0.998 |
| 19:6476891:C:A | R215I | 0.998 |
| 19:6479692:G:C | F51L | 0.998 |
| 19:6479692:G:T | F51L | 0.998 |
| 19:6479694:A:G | F51L | 0.998 |
| 19:6476888:C:G | R216T | 0.997 |
| 19:6476890:T:A | R215S | 0.997 |
| 19:6476890:T:G | R215S | 0.997 |
| 19:6476891:C:G | R215T | 0.997 |
| 19:6476894:T:A | E214V | 0.997 |
| 19:6475332:A:G | F332S | 0.996 |
| 19:6475888:C:G | W243S | 0.996 |
| 19:6476885:A:T | V217D | 0.996 |
| 19:6476960:A:G | L192P | 0.996 |
| 19:6478981:G:C | F84L | 0.996 |
| 19:6478981:G:T | F84L | 0.996 |
| 19:6478983:A:G | F84L | 0.996 |
| 19:6479020:G:C | F71L | 0.996 |
| 19:6479020:G:T | F71L | 0.996 |
| 19:6479022:A:G | F71L | 0.996 |
| 19:6475873:A:G | I248T | 0.995 |
| 19:6476887:T:A | R216S | 0.995 |
| 19:6476887:T:G | R216S | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000017818 (19:6470674 T>C), RS1000244407 (19:6473064 T>A,C), RS1000418310 (19:6468643 G>A), RS1000468877 (19:6478460 C>G,T), RS1000490393 (19:6483771 C>A,G), RS1000744647 (19:6477940 T>G), RS1000798769 (19:6478734 G>A,C,T), RS1000878555 (19:6468890 C>G,T), RS1000987700 (19:6472733 C>T), RS1001054973 (19:6478486 C>T), RS1001332012 (19:6472531 T>C), RS1001421289 (19:6467408 T>C,G), RS1001430626 (19:6470623 T>TTTTTTG), RS1001896818 (19:6470478 C>T), RS1001915954 (19:6474520 G>C)
Disease associations
OMIM: gene MIM:613634 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002002_3 | Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide) | 8.000000e-06 |
| GCST90002393_637 | Monocyte count | 1.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005091 | monocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | increases expression, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| entinostat | increases expression | 1 |
| perfluorohexanesulfonic acid | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Calcitriol | increases expression, affects cotreatment | 1 |
| Coumestrol | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Nickel | increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.